Anil Kapur - Jun 6, 2024 Form 4 Insider Report for GERON CORP (GERN)

Role
EVP, Corp Strategy & CCO
Signature
/s/ Scott A. Samuels for Anil Kapur
Stock symbol
GERN
Transactions as of
Jun 6, 2024
Transactions value $
$0
Form type
4
Date filed
6/7/2024, 04:10 PM
Previous filing
Feb 16, 2024
Next filing
Jun 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GERN Employee Stock Option (right to buy) Award $0 +250K $0.00 250K Jun 6, 2024 Common Stock 250K $1.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance-based stock option granted on December 2, 2019 and vested in full on June 6, 2024 upon approval of the NDA by the US FDA for imetelstat in lower risk MDS.